Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 10—October 2022
Research Letter

Haematospirillum jordaniae Cellulitis and Bacteremia

Emil Pal, Iztok Štrumbelj, Tjaša Cerar Kišek, Marko Kolenc, Mateja Pirš, Katarina Resman Rus, Tina Triglav, and Tatjana Avšič-ŽupancComments to Author 
Author affiliations: Murska Sobota General Hospital Department of Infectious Diseases, Murska Sobota, Slovenia (E. Pal); National Laboratory of Health, Environment and Food, Murska Sobota (I. Štrumbelj); Institute of Microbiology and Immunology, Ljubljana, Slovenia (T. Cerar Kišek, M. Kolenc, M. Pirš, K. Resman Rus, T. Triglav, T. Avšič-Županc)

Main Article


Antimicrobial susceptibility of Haematospirillum jordaniae from a male patient in Slovenia, interpreted according to non–species-related EUCAST PK/PD breakpoints*

Antimicrobial MIC, mg/L Susceptibility category
Benzylpenicillin 8 R
Ampicillin 2 S
Amoxicillin/clavulanic acid 0.125 S
Cefuroxime Iv 16 R
Cefotaxime 0.25 S
Imipenem >32 R
Meropenem 1 S
Ciprofloxacin <0.002 S
Levofloxacin <0.002 S
*EUCAST, PK/PD, pharmacokinetics/pharmacodynamics; R, resistant; S, susceptible

Main Article

Page created: July 31, 2022
Page updated: September 21, 2022
Page reviewed: September 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.